News

Filter

PATH MVI partners with GSK and Crucell to develop second-generation vaccine against malaria

08-06-2011

The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with…

CrucellGlaxoSmithKlineJohnson & JohnsonPharmaceuticalResearchTropical diseasesVaccines

Medivir enters dengue virus R&D collaboration with Johnson & Johnson unit

15-02-2011

Swedish infectious disease drug developer Medivir AB (OMX: MVIR) has signed a collaboration agreement…

Janssen PharmaceuticaJohnson & JohnsonLicensingMedivirPharmaceuticalResearchTropical diseases

Back to top